Products & Services
Newert, Supplier of Biosignal Raw Data and SDKs, Sells Out Its Initial Run of 'EmoConnect PPG&Motion'
Newert, which supplies solutions for research and development in the biosignal field, announced on the 8th that the initial production run of 'EmoConnect PPG&Motion' — the wristband-type biosignal measurement device it recently released — has sold out.
A Newert representative said, "Biosignal measurement devices already on the market often provide raw data and SDKs for applied research and development only in limited form, or not at all. 'EmoConnect PPG&Motion' removes those constraints, and that has drawn strong interest from researchers and developers."
'EmoConnect PPG&Motion' is a wristband-type biosignal measurement device equipped with PPG (photoplethysmography) and IMU (accelerometer, gyroscope, magnetometer) sensors, capable of transmitting and collecting raw data in real time over BLE.
It also applies smart noise filtering technology to counter the drop in measurement accuracy caused by user movement during biosignal measurement, and links with Newert's cloud-based biosignal data platform service (biosignal-datahub) for efficient data storage and management.
Newert CEO Lee Jung-nyeon said, "EmoConnect PPG&Motion is manufactured through planned production using dedicated molds rather than build-to-order, and the second production run is currently underway," expressing confidence about resupply and adding, "Sales will resume shortly."
Further details on EmoConnect PPG&Motion are available on the Newert website.
Reporter Kim Guk-ju press@healthinnews.co.kr
Source: Health in News (https://www.healthinnews.co.kr)
Related news
Newert Achieves Its First Export of EmoConnect PPG&Motion to China
Newert has achieved its first export to the Chinese market with EmoConnect PPG&Motion, the biosignal measurement device for research and development that the company designed in-house. The export was made under a contract with the Chinese corporation "HEBEI KANGHU INTELLIGENT SENSING TECHNOLOGY," marking an important milestone in Newert's move into global markets. Starting with China, the company is sequentially preparing the international certifications required to enter the United States, Europe, and other regions.
Newert Launches Wearable Biosignal Measurement Equipment and Software for R&D, Including Raw Data Access
Few companies in Korea develop and supply solutions for research and development in the biosignal field. Equipment on the market has also tended to restrict movement with wired sensors or to limit the data it provides, making applied R&D and business expansion difficult. Newert (CEO Lee Jung-nyeon) announced on the 16th that it has launched EmoConnect PPG&Motion, a wireless wearable biosignal measurement device supplied together with the raw data it collects and an SDK for commercialization.
Newert Launches a Cloud-Based Biosignal Data Platform Service
Newert (CEO Lee Jung-nyeon), a biosignal specialist providing full-cycle solutions for measuring and analyzing biosignals in everyday life, announced on the 15th that it is launching its cloud-based biosignal data platform service (biosignal-datahub) this month. In research settings today, experiment management and data handling differ from researcher to researcher, and continuity of data management breaks down when the person responsible graduates or moves on. Built on Newert's data standardization system, the platform collects and manages a range of biosignal data including EEG, ECG, PPG, and GSR, and supports its analysis and use.